Mutual funds are subject to market risk. Read all scheme documents carefully.
This fund is not currently rated by our system. However, we continuously review and update our ratings, so it may be included in the future.
Our score weighs long-term performance, risk and consistency — not just past returns.
As of 5 Nov 2026
Long term capital appreciation. Investment predominantly in equity & equity related instruments of mid cap companies
The scheme seeks to generate long term capital appreciation by predominantly investing in equity & equity related instruments of mid cap companies.
Exit load of 1%, if redeemed within 180 days.
As of 30 Sep 2026
| Holding | % of fund | Value | Shares |
|---|---|---|---|
| Multi Commodity Exchange Of India Ltd. | 4.01% | ₹27.51 Cr | 83,364 |
| Dixon Technologies (India) Ltd. | 3.57% | ₹24.51 Cr | 18,711 |
| Lenskart Solutions Ltd. | 3.20% | ₹22 Cr | 3,21,084 |
| Aurobindo Pharma Ltd. | 2.99% | ₹20.55 Cr | 1,22,919 |
| Radico Khaitan Ltd. | 2.90% | ₹19.88 Cr | 45,542 |
| Laurus Labs Ltd. | 2.71% | ₹18.58 Cr | 93,856 |
| Kalyan Jewellers India Ltd. | 2.54% | ₹17.43 Cr | 3,15,089 |
| The Phoenix Mills Ltd. | 2.48% | ₹17.05 Cr | 88,090 |
| The Federal Bank Ltd. | 2.29% | ₹15.72 Cr | 4,95,202 |
| Swiggy Ltd. | 2.25% | ₹15.44 Cr | 6,17,334 |
